Healius | HLS

Stock Price
3.13
Daily Change
1.13%
Yearly
-17.76%
Q2 Forecast
3.02
Rating
Sell

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Peers Price Day Year
Ansell 26.93 0.20 0.75% 3.90%
Cochlear 248.15 3.14 1.28% 13.80%
CSL 311.68 3.68 1.19% 15.07%
Fisher Paykel Healthcare 23.96 -0.42 -1.72% 15.25%
Integral Diagnostics 3.33 0.07 2.15% -2.35%
Mayne Pharma 3.80 -0.10 -2.44% -24.27%
Nanosonics 5.20 0.08 1.46% 50.14%
Polynovo 1.48 -0.02 -1.17% 30.18%
Ramsay Health Care 59.14 1.29 2.23% -22.98%
ResMed 33.26 0.26 0.79% 14.69%
Sonic Healthcare 36.23 0.42 1.17% 4.17%
Sigma Healthcare 0.64 -0.01 -0.78% 26.73%

Indexes Price Day Year
AUALL 7398 67.20 0.92% -0.47%
AU200 7218 72.90 1.02% 0.16%

Healius

Healius Ltd traded at 3.11 this Monday June 5th, increasing 0.02 or 0.49 percent since the previous trading session. Looking back, over the last four weeks, Healius gained 1.80 percent. Over the last 12 months, its price fell by 18.29 percent. Looking ahead, we forecast Healius Ltd to be priced at 3.02 by the end of this quarter and at 2.81 in one year, according to Trading Economics global macro models projections and analysts expectations.

Healius Limited is an Australia-based healthcare company. The Company operates through three segments: Pathology, Imaging, and Day Hospitals. The Pathology segment is a provider of pathology services. The Imaging segment is a provider of imaging and scanning services from standalone imaging sites, hospitals, and medical centers. The Day Hospitals segment is an operator of day hospitals. The Company has a network of pathology laboratories, diagnostic imaging centers, day hospitals, and In-Vitro Fertilization (IVF) clinics. It provides specialty diagnostic services to consumers and their referring practitioners, as well as supporting independent healthcare professionals in the delivery of care in its centers, day hospitals and fertility clinics. It also offers diagnostics, veterinary pathology services to veterinarians. The Company’s brands include QML Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, and Genomic Diagnostic.